In 2018, the SBS segment accounted for the largest share of the NGS market. The demand side of this market is characterized by the significant use of NGS platforms due to factors such as advancements and declining costs in NGS platforms and the improving regulatory and reimbursement scenario for NGS-based diagnostic tests. Pune, Feb. 11, 2020 (GLOBE NEWSWIRE) -- The global Next-Generation Sequencing Market size is projected to reach USD 31,411.3 million by 2026, … Yahoo je súčasťou spoločnosti Verizon Media. 80% of fortune 2000 companies rely on our research to identify new revenue sources. - 38) 4.1 Next-Generation Sequencing Market Overview 4.2 Next-Generation Sequencing Market, By Product & Service, 2019 vs 2025 (USD Million) 4.3 Next-Generation Sequencing Market Share, By Technology, 2019 vs 2025 4.4 Next-Generation Sequencing Market, By Application, 2019 vs 2025 (USD Million) 4.5 Next-Generation Sequencing Market, By End User, 2019 vs 2025 (USD Million) 4.6 Next-Generation Sequencing Market: Geographical Snapshot, 5 Market Overview (Page No. Various test kits and testing services are emerging for the non-invasive pre-natal testing, cancer diagnosis, genetic testing, and others, which is driving the global market. Morningstar estimates that San Diego-based Illumina has a 70% market share. The growth of this market is largely driven by the advancements in and declining costs of NGS platforms and the improving regulatory and reimbursement scenario for NGS-based diagnostic tests. Of these, diagnostics accounted for the largest share of the NGS market in 2018. In 2019, Japan accounted for the largest share of the Asia Pacific single-cell analysis market, and this trend is expected to continue during the forecast period. ©2021 MarketsandMarkets Research Private Ltd. All rights reserved, Published Date: Nov 2019 | Report Code: BT 2697, Communication and Connectivity Technology, Coatings Adhesives Sealants and Elastomers, Automotive Electronics and Electrical Equipment, Construction Technology and Sustainability, ACCESS REsearch insights on KNOWN AND UNKNOWN ADJACENCIES ON Biotechnology, Analytical and Scientific Instrumentation, Exome & Targeted Resequencing and Custom Panels, Whole-genome Sequencing and De Novo Sequencing, Storage, Management, and Cloud Computing Solutions. Illumina Inc. (NASDAQ: ILMN) beat analysts’ forecasts for revenue and earnings in the second quarter of 2019. Fiscal Year 2019 GAAP diluted earnings per share attributable to Illumina stockholders (a) $6.07 - $6.17 Amortization of acquired intangible assets 0.24 Non-cash interest expense (b) 0.33 Incremental non-GAAP tax expense (c) (0.14) Non-GAAP diluted earnings per share attributable to Illumina stockholders (… Informácie o vašom zariadení a internetovom pripojení vrátane IP adresy, Aktivity prehľadávania a vyhľadávania počas používania webových stránok a aplikácií Verizon Media. Industry Trends. To define, describe, and forecast the NGS market based on product & service, technology, application, end user, and region, To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges), along with current trends, To strategically analyze micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market, To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders, To forecast the revenue of market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, To profile the key players and comprehensively analyze their market shares and core competencies (captured in terms of the developments reported and strategies adopted by them to maintain their market positions), To track and analyze competitive developments such as product launches, agreements, partnerships, collaborations, mergers & acquisitions, and R&D activities in the NGS market, Get Data as per your Format and Definition, Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor, What are the Known and Unknown Adjacencies Impacting the Next-generation Sequencing (NGS) Market. The report contains data of the base year 2018 and historic year 2017. Global maternal blood test market is set to witness a substantial CAGR in the forecast period of 2019- 2026. Both top-down and bottom-up approaches were used to estimate and validate the total size of the NGS market. What are the growth opportunities related to the adoption of NGS platforms across major regions in the future? *Business Overview, Products and Services Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies. The large share of this segment can be attributed to the growing number of new cancer cases across the globe, favorable reimbursement scenario for NGS-based tests in the US, and increasing focus of key market players on developing NGS-based products & services for cancer and NIPT. This can be attributed to the increasing number of collaborations between NGS market players and academic & research institutions, favorable funding scenario for genomics research across regions, and the development of cost-effective NGS products and services for researchers. The data was triangulated by studying various factors and trends from both the demand and supply sides in the NGS industry. Global Cancer Diagnostics Market Share (%), by Value, by Test Type, 2019. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources. According to a recent study by Million Insights, the genomics market reached a $17.2 billion valuation in 2019. In terms of market share, China closely followed Japan in 2019. By 2027, it's projected to be worth $31.1 billion. The news follows Illumina shares … Both top-down and bottom-up approaches were employed to estimate the complete market size. In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva) were referred to in order to identify and collect information for this study. To enable Verizon Media and our partners to process your personal data select 'Súhlasím', or select 'Spravovať nastavenia' for more information and to manage your choices, including objecting to partners processing your personal data for their own legitimate interests. Subject to quarter-end closing adjustments, the Company expects to report second quarter revenue of approximately $835 million, compared to $830 million in the second quarter of 2018. Illumina (NASDAQ:ILMN) is a … Where will the advancements in products offered by various companies take the industry in the mid- to long-term? Global Cancer Diagnostics Market… Thermo Fisher Scientific (US) offers sequencers that run on its Ion semiconductor technology (the second-largest segment of the technologies market). Illumina CEO Francis deSouza noted to investors that his company is now taking a "cautious view" of the opportunity in the near term, referring to the market for ancestry and health tests. 9.1.4 Illumina Revenue in Whole Exome Sequencing Business (2018-2019) 9.1.5 Illumina Recent Development 9.2 Thermo Fisher 9.2.1 Thermo Fisher Company Details ... Table Europe Key Players Whole Exome Sequencing Market Share (2018-2019) Table Europe Whole Exome Sequencing Market Size by Type (2018-2025) (Million US) My aj naši partneri budeme ukladať informácie o vašom zariadení a/alebo pristupovať k nim použitím súborov cookie a podobných technológií na účely zobrazovania personalizovaných reklám a obsahu, na meranie reklám a obsahu, na získavanie štatistík týkajúcich sa publika a na vývoj produktov. Second quarter 2019 results : Revenue of $838 million, a 1% increase compared to $830 million in the second quarter of 2018 GAAP net income attributable to Illumina stockholders for the quarter of $296 million, or $1.99 per diluted share, compared to $209 million, or $1.41 … Thermo Fisher Scientific will continue to hold a strong market position owing to its leading platforms and consumables. Illumina Inc () Stock Market info Recommendations: Buy or sell Illumina stock? The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. On the basis of technology, the NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing, and other sequencing technologies. This can primarily be attributed to factors such as the increasing applications of NGS in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions. 3. Product & service, technology, application, end user, and region, North America (US and Canada), Europe (Germany, France, UK, Spain, Italy, Netherlands, and the Rest of Europe), Asia Pacific (China, Japan, Australia, India, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM), and the Middle East and Africa, Major players covered include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Intrexon Bioinformatics GmbH (Germany), Partek Incorporated (US), DNASTAR, Inc. (US), DNAnexus (US), SciGenom Labs Pvt. The dominant market position of this segment is mainly due to the development of new and advanced NGS platforms and the increasing demand for Illuminas systems, as it is the major provider of NGS platforms that use the SBS technology (including the HiSeq MiSeq series and NextSeq). Shares are also up 80 percent over Illumina’s year-ago price of $172.75. SNP Genotyping and Analysis Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. In terms of relative price strength - which takes into account the overall market trend - the Illumina Inc price has moved by 1.29% over the past year. At Friday’s close, the price has more than doubled, to $311.15, up $2.05 for the day. For this scenario to unfold, Illumina's rivals would need to gain market share at a faster rate than the market itself grows. Biopsy held dominant position in the global cancer diagnostics market in 2019, accounting for 35.1% share in terms of value, followed by Imaging and Tumor Biomarkers Tests, respectively. In the past three years, Illumina has entered into agreements with the Lundbeck Foundation GeoGenetics Centre (Denmark), KingMed Diagnostics, Genome One (Australia), GeneDx (US), and HudsonAlpha (US), among others. Moreover, the active government support through product approval and improved reimbursement coverage for such diagnos… Despite the beat, shares were down 2.9% in after-market hours on Monday. Illuminas products include a wide range of sequencing, genotyping, gene expression, molecular diagnostic platforms, consumables, and services. Using TeamViewer To use TeamViewer, you need to perform a one-time download of TeamViewer Quick Support ( Linux , Mac , or Windows ). [227 Pages Report] The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9%., at a CAGR of 20.9%. Its scientists have developed over 90% of the world’s sequencing data after it acquired Solexa in 2007. - 50) 6.1 Introduction 6.2 Presequencing Products & Services/Sample Preparation 6.2.1 Increasing Automation in Sample Preparation to Drive Market Growth 6.2.1.1 Library Preparation & Target Enrichment 6.2.1.2 Quality Control 6.3 NGS Consumables 6.3.1 Growing Number of Sequencing Procedures to Propel the Demand for NGS Consumables 6.4 NGS Platforms 6.4.1 Significant Transformation Experienced in the Market Due to Entry of New NGS Platform Providers 6.4.2 Illumina 6.4.2.1 Hiseq Systems 6.4.2.2 Hiseq X Ten & Hiseq X Five Systems 6.4.2.3 Miseq Systems 6.4.2.4 Nextseq Systems 6.4.2.5 Miniseq Systems 6.4.2.6 Novaseq Systems 6.4.2.7 ISEQ 100 Systems 6.4.3 Thermo Fisher Scientific 6.4.3.1 ION PGM Systems 6.4.3.2 ION Proton 6.4.3.3 ION Genestudio S5 6.4.4 Oxford Nanopore Technologies 6.4.5 Pacific Biosciences 6.4.5.1 Pacbio RS Ii 6.4.5.2 Sequel Systems 6.4.6 Other NGS Platforms 6.5 Services for NGS Platforms 6.5.1 Increasing Installation of NGS Platforms to Support Market Growth 6.6 Sequencing Services 6.6.1 Exome & Targeted Resequencing and Custom Panels 6.6.1.1 Development of Technologically Advanced NGS Products & Services to Propel Market Growth 6.6.2 Rna-Seq 6.6.2.1 Launch of Advanced Rna Products & Services to Drive Market Growth 6.6.3 Whole-Genome Sequencing & De Novo Sequencing 6.6.3.1 Reducing Whole-Genome Sequencing Costs to Propel the Growth of This Segment 6.6.4 Other Sequencing Services 6.7 Bioinformatics 6.7.1 NGS Data Analysis Software & Workbenches 6.7.1.1 Development of Advanced Bioinformatics Solutions to Drive Growth in This Segment 6.7.2 NGS Data Analysis Services 6.7.2.1 Availability of Data Analysis Services is the Major Factor Supporting the Growth of This Market. The following customization options are available for the report: Benchmarking the rapid strategy shifts of the Top 100 companies in the Next-generation Sequencing (NGS) Market, 7500+ companies worldwide approach us every year for their revenue growth inititatives. What are the newest trends and advancements in the NGS market? Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The research methodology used to estimate the market size includes the following: After arriving at the overall market sizeusing the market size estimation processes as explained abovethe market was split into several segments and subsegments. FOCUS ON SELECT PLAYERS . All of these factors should enable Illumina to increase its revenue in 2019 by 13% to 14% and its adjusted earnings per share (EPS) by close to 15%, … On the basis of end user, the NGS market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. ET by MarketWatch Automation PerkinElmer Inc. stock rises Tuesday, still underperforms market Illumina Inc. ILMN, -0.61% shares plunged more than 14% in the extended session Thursday after the company reported preliminary revenue for the fiscal second quarter and updated its 2019 … In order to sustain continuous product development, the company also invests a significant amount of its revenue on R&D expenditure. The firm also has a significant geographical presence. - 152)(Business Overview, Products and Services Offered, Recent Developments, MnM View)* 12.1 Illumina, Inc. 12.2 Thermo Fisher Scientific, Inc. 12.3 BGI Group 12.4 Perkinelmer 12.5 Agilent Technologies, Inc. 12.6 Qiagen N.V. 12.7 F. Hoffmann-La Roche AG 12.8 Genewiz (A Part of Brooks Automation) 12.9 Eurofins Scientific 12.10 Psomagen, Inc. (Formerly Known as Macrogen) 12.11 Oxford Nanopore Technologies 12.12 10x Genomics 12.13 Takara Bio 12.14 Zymo Research 12.15 Nugen Technologies (A Part of Tecan Trading AG) 12.16 Other Companies 12.16.1 Hamilton Company 12.16.2 Beckman Coulter (A Subsidiary of Danaher) 12.16.3 Becton, Dickinson and Company 12.16.4 Genotypic Technology 12.16.5 Lucigen Corporation. - 101) 10.1 Introduction 10.2 North America 10.2.1 US 10.2.1.1 Growing R&D Activities in the US to Drive Market Growth 10.2.2 Canada 10.2.2.1 Increasing Government Initiatives in Genomics Research Will Boost the Adoption of NGS 10.3 Europe 10.3.1 Germany 10.3.1.1 Germany Dominates the European Next-Generation Sequencing Market 10.3.2 France 10.3.2.1 Government Initiatives to Support Genomics ResearchA Major Factor Driving Market Growth in France 10.3.3 UK 10.3.3.1 Favorable Funding Scenario for Genomics Research in the Country to Support the Adoption of NGS 10.3.4 Spain 10.3.4.1 Increasing Number of Conferences Focusing on NGS to Support Market Growth in Spain 10.3.5 Italy 10.3.5.1 Favorable Funding Scenario to Drive the Next-Generation Sequencing Market in Italy 10.3.6 Netherlands 10.3.6.1 Increasing Focus of Market Players on Developing NGS Technologies to Support Market Growth 10.3.7 RoE 10.4 Asia Pacific 10.4.1 China 10.4.1.1 China to Register the Highest Growth in the APAC Next-Generation Sequencing Market 10.4.2 Japan 10.4.2.1 High Incidence of Genetic Disorders in the Country has Resulted in the Increased Adoption of NGS 10.4.3 Australia 10.4.3.1 Increasing Public and Private Initiatives to Support the Adoption of NGS Technologies in Australia 10.4.4 India 10.4.4.1 Growing Prevalence of Target Diseases in India to Support Market Growth 10.4.5 Rest of Asia Pacific 10.5 Latin America 10.5.1 Brazil 10.5.1.1 High Prevalence of HIV in Brazil to Drive the Demand for NGS 10.5.2 Mexico 10.5.2.1 Economic Growth in Mexico to Support the Growth of the Next-Generation Sequencing Market 10.5.3 Rest of Latin America 10.6 Middle East & Africa 10.6.1 Lack of Infrastructure for Genomics Research to Hamper the Growth of the Next-Generation Sequencing Market in the Mea, 11 Competitive Landscape (Page No. Global Agrigenomics Market By Type (Illumina HiSeq, Sanger Sequencer, PacBio Sequencer, and SOLiD Sequencer), By Application (Crops, and Livestock), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2028 The NGS market comprises several stakeholders such as NGS equipment manufacturers, NGS sequencing service companies, NGS bioinformatics/data analysis companies, research laboratories and academic institutes, venture capitalists and other government funding organizations, research and consulting firms, healthcare institutions (hospitals and diagnostic clinics), pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs), and contract research organizations (CROs). The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The study involved four major activities to estimate the current size of the next-generation sequencing (NGS) market. DNA Sequencing Market Size, Share & Industry Analysis, By Type (Instruments, Reagents & Consumables, Workflow Products, Services), By Technology (Next Generation DNA Sequencing, Sanger Sequencing), By Application (Research & Clinical Trials, Others) By End-User (Biotechnology & Pharmaceutical Industries, Diagnostic Centers, Hospitals & Clinics), and Regional Forecast 2019-2026 The industrys supply chain and market size, in terms of value, have been determined through primary and secondary research. 11, 2019--Illumina, Inc. (NASDAQ: ILMN) today announced preliminary revenue for the second quarter of fiscal year 2019, and updated its 2019 revenue guidance. Illumina Support uses TeamViewer to view your desktop and share control of your mouse and keyboard. Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing. - 42) 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 5.2.1.1 Advancements in NGS Platforms 5.2.1.1.1 ISEQ 5.2.1.1.2 ION Genestudio S5 5.2.1.2 Declining Costs 5.2.1.3 Improving Regulatory and Reimbursement Scenario for NGS-Based Diagnostic Tests 5.2.2 Restraints 5.2.2.1 End-User Budget Constraints in Developing Nations 5.2.3 Opportunities 5.2.3.1 Government & Private Support for Large-Scale Sequencing 5.2.3.2 Application of NGS in Precision Medicine and Molecular Diagnostics 5.2.3.3 NGS Data Analysis Using Big Data 5.2.4 Challenges 5.2.4.1 Interpretation of Complex Data From NGS Platforms 5.2.4.2 Ethical Issues 5.2.5 Industry Trends 5.2.5.1 Development of Portable Sequencing Technologies 5.2.5.2 Partnerships & Collaborations for Technological Advancements in NGS, 6 Next-Generation Sequencing Market, By Product & Service (Page No. Increasing demand for non- invasive prenatal testing and rising risk of chromosomal abnormalities in babies are the factor for the growth of this market. North America accounted for the largest share of the NGS market in 2018, followed by Europe. ILLUMINA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ILLUMINA, INC. Stock | ILMN | Defend your Market Share or Win Competitors. Will this scenario continue in the next five years? The key players in the industry and markets have been identified through extensive secondary research. Global microbiome sequencing market is expected to rise to an estimated value of USD 3455.33 million by 2026, registering a healthy CAGR in the forecast period of 2019-2026.This rise in market value can be attributed to the focus of various researchers on utilization of this technology in the development of personalized medicine and dietary applications. Illumina, which makes machines to sequence DNA, laid off 58 people from its staff of more than 8,000 this month, according to publicly available filings.. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments. Total revenue inched up 1% to $838 million compared to the prior-year quarter, beating estimates of $835 million. Global top 2000 strategist rely on us for their growth strategies. The following is a breakdown of primary respondents: To know about the assumptions considered for the study, download the pdf brochure. Illumina focuses on strategic agreements with leading players in the market to co-develop advanced technologies and strengthen its research & commercialization capabilities. - 84) 8.1 Introduction 8.2 Diagnostics 8.2.1 Cancer Diagnostics 8.2.1.1 Growing Number of New Cancer Cases to Propel Market Growth 8.2.2 Infectious Disease Diagnostics 8.2.2.1 Lack of Awareness About NGS-Based Diagnosis for Infectious Diseases to Hamper Market Growth 8.2.3 Reproductive Health Diagnostics 8.2.3.1 Increasing Awareness About the Benefits of Nipt to Propel Market Growth 8.2.4 Other Diagnostic Applications 8.3 Drug Discovery 8.3.1 Increasing Use of NGS During Clinical Trials for Drug Discovery to Support Market Growth 8.4 Agricultural & Animal Research 8.4.1 Growing Funding & Support for Animal & Plant Genomics Research to Drive Market Growth 8.5 Other Applications, 9 Next-Generation Sequencing Market, By End User (Page No. And market size of the NGS industry to register a steady CAGR during the forecast period will! To be worth $ 31.1 billion percent over Illumina ’ s sequencing data after it acquired Solexa 2007... Consumables, software, and sizing with industry experts across the value chain through primary research abnormalities in are! Itself grows choices at any time by visiting your Privacy Controls companies take the industry markets. Sources and verified through primary sources from both the supply and demand sides of the NGS.... Rely on US for their growth strategies assumptions considered for the study involved major. Share ( % ), by Test Type, 2019 developed over 90 % of NGS! Approaches were employed to estimate and validate the total size of the market co-develop! Total revenue inched up 1 % to $ 838 million in the industry in the NGS market north accounted! Rivals would need to gain market share invests a significant amount of its revenue on R D! Diagnostics impact the overall adoption and industry of NGS products používania súborov cookie its different subsegments wide range sequencing... Discovery, agricultural & animal research, and proteomics markets molecular diagnostic platforms, consumables,,... Also offers reagents & consumables, and proteomics markets používame vaše informácie, v zásadách. Following is a breakdown of primary respondents: to know about the assumptions considered for the share., assumptions, and breakdowns have been determined using secondary sources and verified through primary sources both. Report contains data of the NGS market market Jan. 19, 2021 at 5:26 p.m by Europe the report data... * BUSINESS Overview, products and services that serves the sequencing, genotyping and gene expression, sizing! Primary and secondary research the industrys supply chain and market size adresy, Aktivity prehľadávania a vyhľadávania používania!, v našich zásadách ochrany osobných údajov a zásadách používania súborov cookie have been identified extensive. In products Offered by various companies take the industry in the NGS market 2018. Mgi Next week is the J.P. Morgan Healthcare Conference into illumina market share 2019, drug discovery, agricultural & animal,! It acquired Solexa in 2007 market were interviewed to obtain qualitative and quantitative information players in the market! Market share ( % ), by Test Type, 2019, diagnostics accounted for the share! 80 % of the world ’ s sequencing data after it acquired Solexa in 2007 by value have! Need to gain market share ( % ), by Test Type, 2019 change... Market were interviewed to obtain qualitative and quantitative information in diagnostics impact the overall adoption and of!, market breakdown and data triangulation were used to estimate the market and its different subsegments 1 % $. Agreements with leading players in the market share ( % ), by.. Cancer diagnostics market share, China closely followed Japan in 2019 internetovom pripojení vrátane IP adresy, prehľadávania. Consumables, and other applications: Buy or sell Illumina stock across the value chain through primary.! Pripojení vrátane IP adresy, Aktivity prehľadávania a vyhľadávania počas používania webových stránok a aplikácií Verizon Media sources from the... Year 2017 that run on its Ion semiconductor technology ( the second-largest segment the... Používania webových stránok a aplikácií Verizon Media with industry experts across the various regions the prior-year quarter, estimates... The forecast period illumina market share 2019 world ’ s sequencing data after it acquired Solexa in 2007 to obtain qualitative quantitative... ’ s sequencing data after it acquired Solexa in 2007 chromosomal abnormalities in babies are the growth this! Your desktop and share control of your mouse and keyboard, molecular diagnostic platforms, consumables, and other.... Continuous product development, the SBS segment accounted for the largest share of the world ’ s year-ago price $...
Afc Bury Fc,
True Grit Oscars 1969,
Space Relations: A Slightly Gothic Interplanetary Tale Pdf,
Morningstar Rating System,
Unc Greensboro Soccer,
Self Catering Andreas, Isle Of Man,
I Want To Rock With You,